Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZAI LAB

28.250
+0.8503.10%
Volume:5.10M
Turnover:143.10M
Market Cap:30.96B
PE:-13.99
High:28.400
Open:28.000
Low:27.650
Close:27.400
Loading ...

BRIEF-Zai Lab Ltd Commenced Underwritten Public Offering Of $200 Million Of Adss

Reuters
·
14 Nov 2024

Zai Lab Ltd: Commenced Underwritten Public Offering of $200.0 Mln of Adss

THOMSON REUTERS
·
14 Nov 2024

Zai Lab's Q3 Loss Narrows as Revenue Grows; Shares Plunge 8%

MT Newswires Live
·
13 Nov 2024

Zai Lab Ltd reports results for the quarter - Earnings Summary

Reuters
·
13 Nov 2024

Zai Lab Ltd expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
09 Nov 2024

BRIEF-Zai Lab Reports Positive Topline Data From Phase 3 Bridging Trial Evaluating Karxt For The Treatment Of Schizophrenia In China

Reuters
·
29 Oct 2024

Zai Lab Ltd - Karxt Shows Tolerable Safety Profile With No New Safety Signals

THOMSON REUTERS
·
29 Oct 2024

Zai Lab Ltd - Karxt Shows 9.2-Point Reduction in Panss Total Score at Week 5 VS Placebo

THOMSON REUTERS
·
29 Oct 2024

Zai Lab Reports Positive Topline Data From Phase 3 Bridging Trial Evaluating Karxt for the Treatment of Schizophrenia in China

THOMSON REUTERS
·
29 Oct 2024

Zai Lab Ltd - to Submit Nda for Karxt to Nmpa in Early 2025

THOMSON REUTERS
·
29 Oct 2024

Zai Lab Ltd - Trial Meets All Secondary Endpoints With Significant Reductions in Schizophrenia Symptoms

THOMSON REUTERS
·
29 Oct 2024

Stock Track | Zai Lab Stock Soars on Promising Pharmaceutical Developments

Stock Track
·
26 Oct 2024

Stock Track | Zai Lab Stock Surges on Promising Pharmaceutical Developments

Stock Track
·
25 Oct 2024

Stock Track | Zai Lab Stock Soars 11.66% on Positive Pharmaceutical Development

Stock Track
·
25 Oct 2024

Hong Kong Stocks Open Mixed, Zai Lab Soars 10%, Pop Mart Plunges Over 5%

Market Watcher
·
25 Oct 2024

BUZZ-Zai Lab gains on early data from lung cancer drug study

Reuters
·
24 Oct 2024